alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
565 P.2d 890

#### Donald Arthur FAWKES, Appellant, v. Sharon Elaine FAWKES, Appellee.

No. 2 CA-CIV 2322.

Court of Appeals of Arizona, Division 2.

Feb. 22, 1977.

*385Bachstein & Coffey, P. C. by Harry S. Bachstein, Jr., Tucson, for appellant.

Michael J. Vingelli, Tucson, for appellee.

OPINION

HATHAWAY, Judge.

This appeal requires us to once again address the issue of whether A.R.S. § 25-327(B) relating to termination of spousal maintenance upon remarriage or death applies to a fixed spousal maintenance award payable in monthly installments for a limited number of months. We recently determined that A.R.S. § 25-327(B) applies to “all ‘future maintenance’ whether periodic or lump sum.” *Fye v. Zigoures,*Ariz.App., 562 P.2d 1077, 1079 (filed January 13, 1977). We re-affirm this holding and find therefore that the judgment of the lower court must be reversed.

The pertinent facts of this case are as follows. On October 6, 1975, a decree of dissolution was entered terminating the marriage of appellant and appellee. The decree provided that . . Petitioner [Donald Fawkes] pay to Respondent, effective July 1, 1975, the sum of $100.00 per month for a period of one (1) year, as and for spousal maintenance . . . ’ Sharon Fawkes remarried during January 1976, and appellant ceased making payments at that time. On March 15, 1976, appellee filed a Petition for Order to Show Cause Re: Contempt. She alleged that appellant was in arrears for payments due in January, February and March. After a hearing, the trial judge found the appellant to be in contempt and granted judgment in favor of appellee for amounts due from January through April 1976. Appellee was awarded her attorney’s fees and the court ordered that appellant could purge himself of contempt by making the missed payments.

Following *Fye v. Zigoures,*we hold that appellant’s obligation to make spousal maintenance payments terminated upon the remarriage of his former spouse. We reverse and remand with instructions that the trial court enter an order relieving appellant from the obligation to make payments subsequent to appellee’s remarriage. We also reverse the judgment awarding appellee her attorney’s fees.

HOWARD, C. J., and RICHMOND, J., concur.
EXHIBIT 99.1
 SECTION 906 CERTIFICATIONS



Each of the undersigned
hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Provena Foods Inc. (the Company), that, to his knowledge, the Quarterly Report of
the Company on Form 10-Q for the period ended March 31, 2003, fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all
material respects, the financial condition and results of operation of the Company.



|                    
|--------------------
|Date: April 24, 2003
|                    



|
|
|
|



-12-
|   | 1. | I have reviewed this Quarterly Report on Form 10-Q of Crimson Exploration Inc.; |
|--------|----|---------------------------------------------------------------------------------|

|   | 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:       | November 10, 2010       |   |
|--------------------------------------|-------------------------|--------|
|                                 | /s/ E. Joseph Grady     |   |
| Name:                      | E. Joseph Grady         |   |
| Title:           | Senior Vice President   |   |
|                                 | Chief Financial Officer |   |
Exhibit 32

    Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
                  Section 906 of the Sarbanes-Oxley Act of 2002


August 15, 2005


Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549


Re:  Certification Required Under Section 906 of Sarbanes-Oxley Act of 2002

In  connection  with the  accompanying  report on Form 10-Q for the period ended
June 30, 2005, and filed with the Securities and Exchange Commission on the date
hereof  (the  "Report"),  we,  Allan  D.  Keel,  President  and  CEO of  Crimson
Exploration Inc. (the "Company"), and E. Joseph Grady, Senior Vice President and
Chief Financial Officer of the Company hereby certify that:

     1. The report fully  complies  with the  requirements  of Section  13(a) or
15(d) of the Securities Exchange Act of 1934; and

     2. The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.


Crimson Exploration Inc.


/s/   Allan D. Keel
-------------------------------
By: Allan D. Keel
President and Chief Executive Officer


/s/   E. Joseph Grady
-------------------------------
By: E. Joseph Grady
Senior Vice President and Chief Financial Officer
<PAGE>

                                                                    EXHIBIT 10.1

                              Terms of Compensation

Name: David Henry

Title: Senior Vice President and Chief Financial Officer

Base Salary: $275,000

Bonus Plan: $40,000 one-time net hire date bonus

      Eligible for participation in the company's Key Manager Incentive Program
      with a target payout at 60% of base salary and a maximum payout of 150% of
      base salary

Stock Options: Eligible to participate in the Amended and Restated AMIS
      Holdings, Inc. 2000 Equity Incentive Plan. In 2005, received stock options
      to purchase 50,000 shares, with an exercise price = fair market value on
      grant date, vesting 1/4 on the first anniversary of the grant date and an
      additional 1/48 monthly thereafter

Health Benefits: Eligible for group insurance program consisting of a
      hospital, surgical, major medical, life, dependent life, accidental death
      insurance and dental plan, and an annual executive physical

401K: Company match of 50% of the employee's first 6% contribution, not to
      exceed 50% of the 402(g) limit

Relocation: Relocation Assistance from Maine to Pocatello, Idaho
§ 522.158 Bedinvetmab. ( a ) *Specifications.* Each single-use vial contains 5, 10, 15, 20, or 30 milligrams (mg) bedinvetmab in an extractable volume of 1 milliliter.
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use* — ( 1 ) *Amount.* Administer 0.23 mg/pound (0.5 mg/kilogram) body weight monthly by subcutaneous injection.
( 2 ) *Indications for use.* For the control of pain associated with osteoarthritis in dogs.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[88 FR 55564, Aug. 16, 2023]
§ 1230.37 Publication. ( a ) After judgment of the court in any proceeding under the Federal Caustic Poison Act, notice shall be given by publication. Such notice shall include the findings of the court and may include the findings of the analyst and such explanatory statements of fact as the Secretary of Health and Human Services may deem appropriate.
( b ) This publication may be made in the form of a circular, notice, or bulletin, as the Secretary of Health and Human Services may direct.
( c ) If an appeal be taken from the judgment of the court before such publication, that fact shall appear.
Exhibit 31.4


CERTIFICATIONS





I, John G. Cooper, certify that:





1.           I have reviewed this Amendment No. 1 on Form 10-K/A for the fiscal year ended December 31, 2010 of Discovery Laboratories, Inc.; and





2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.








Date:  April 29, 2011

/s/ John G. CooperJohn G. CooperPresident and Chief Financial Officer
§ 526.1810 Pirlimycin. ( a ) *Specifications.* Each single-dose, 10-milliliter syringe contains 50 milligrams (mg) of pirlimycin (as pirlimycin hydrochloride).
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Related tolerances.* See § 556.515 of this chapter.
( d ) *Conditions of use in lactating cows* — ( 1 ) *Amount.* Infuse the contents of one syringe (50 mg pirlimycin) into each infected quarter. Daily treatment may be repeated at 24-hour intervals for up to 8 consecutive days.
( 2 ) *Indications for use.* For the treatment of clinical and subclinical mastitis in lactating dairy cattle associated with *Staphylococcus* species such as *Staphylococcus aureus* and *Streptococcus* species such as *Streptococcus agalactiae*, *Streptococcus dysgalactiae*, and *Streptococcus uberis.*
( 3 ) *Limitations.* Milk taken from animals during treatment and for 36 hours following the last treatment must not be used for food regardless of treatment duration. Following infusion twice at a 24-hour interval, treated animals must not be slaughtered for 9 days. Following any extended duration of therapy (infusion longer than twice at a 24-hour interval, up to 8 consecutive days), animals must not be slaughtered for 21 days. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[58 FR 58486, Nov. 2, 1993, as amended at 65 FR 61091, Oct. 16, 2000; 73 FR 811, Jan. 4, 2008; 79 FR 10973, Feb. 27, 2014; 86 FR 13188, Mar. 8, 2021]
#### Bilo *v.*International Smelting & Refining Company.

[No. 17,211.

Filed April 15, 1944]

*601*Martin Karmilowicz*and *Dommie P. Sewald,*both of East Chicago, for appellant.

*R. M. Royce, Bomberger, Morthland & Royce,*of Hammond, for appellee.

Crumpacker, C. J.

This is an appeal from an award of the Industrial Board of Indiana whereby compensation was denied the appellant for alleged accidental injury arising out of and in the course of her employment with the appellee. The matter comes to us upon a single assignment of error charging that said award is contrary to law.

It is undisputed that the appellant was employed by the appellee from November 11, 1930, until March 30, 1940, as a “janitress” and as such was required to scrub tile floors and cement stairways on her hands and knees. Sometime in 1939 she began to suffer pain in her knee joints which was subsequently determined to be caused by arthritis. The appellant contends that such arthritis is of traumatic origin and directly attributable to long and constant contact with the hard floors and stairways upon which she was required to work'on her knees in the ordinary and usual course of her employment. The appellee contends, on the other hand, that the appellant’s arthritis is of the rheumatoid type and was neither caused nor aggravated by anything she did nor by any mishap she may have suffered while in its employment. There is evidence to support both contentions and on that state of the record the Industrial Board made the following finding upon which an award denying compensation was entered:

> *602“It is further found that while in the employ of the defendant the said plaintiff was afflicted with a rheumatoid arthritis. That said affliction was neither caused by or aggravated by an accidental injury arising out of and in the course of her employment with the defendant, but said affliction was due to other causes.”

To determine the facts was wholly and exclusively within the province of the Industrial Board and its findings in that regard, being supported by ample evidence, are beyond our reach. As no other question is presented either by the record or briefs of counsel the award must be affirmed.

Note. — Reported in 53 N. E. (2d) 1017.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of State

          - [Public Notice 6908]

# SUMMARY:

                        Notice is hereby given of the following determinations: Pursuant to the authority vested in me by the Act of October 19, 1965 (79 Stat. 985; 22 U.S.C. 2459), Executive Order 12047 of March 27, 1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 Stat. 2681,                         *et seq.;*22 U.S.C. 6501 note,                         *et seq.*), Delegation of Authority No. 234 of October 1, 1999, Delegation of Authority No. 236 of October 19, 1999, as amended, and Delegation of Authority No. 257 of April 15, 2003 [68 FR 19875], I hereby determine that the objects to be included in the exhibition “Vienna Circa 1780: An Imperial Silver Service Rediscovered,” imported from abroad for temporary exhibition within the United States, are of cultural significance. The objects are imported pursuant to loan agreements with the foreign owners or custodians. I also determine that the exhibition or display of the exhibit objects at The Metropolitan Museum of Art, New York, NY, from on or about April 13, 2010, until on or about November 7, 2010, and at possible additional exhibitions or venues yet to be determined, is in the national interest. I have ordered that Public Notice of these Determinations be published in the                         **Federal Register**                        .                    

# FOR FURTHER INFORMATION CONTACT:

For further information, including a list of the exhibit objects, contact Julie Simpson, Attorney-Adviser, Office of the Legal Adviser, U.S. Department of State (telephone: 202-632-6467). The mailing address is U.S. Department of State, SA-5, L/PD, Fifth Floor (Suite 5H03), Washington, DC 20522-0505.

      ( print page 9014)    
Dated: February 23, 2010.

Maura M. Pally,

Deputy Assistant Secretary for Professional and Cultural Exchanges, Bureau of Educational and Cultural Affairs, Department of State.

[FR Doc. 2010-4153 Filed 2-25-10; 8:45 am]

BILLING CODE 4710-05-P
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE FINANCIAL DATA SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM THE CONDENSED CONSOLIDATED BALANCE SHEETS AND THE CONDENSED STATEMENTS OF
OPERATIONS FOUND ON PAGES F-3 AND F-4 OF THE COMPANY'S FORM 10-K FOR THE TWELVE
MONTHS ENDED JULY 31, 1997, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUL-31-1997
<PERIOD-END>                               JUL-31-1997
<CASH>                                       4,960,612
<SECURITIES>                                         0
<RECEIVABLES>                               40,941,907
<ALLOWANCES>                                 3,213,653
<INVENTORY>                                 47,239,520
<CURRENT-ASSETS>                            93,710,110
<PP&E>                                      18,416,904
<DEPRECIATION>                               3,431,017
<TOTAL-ASSETS>                             129,905,574
<CURRENT-LIABILITIES>                       82,236,645
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,000
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>               125,905,574
<SALES>                                    137,386,257
<TOTAL-REVENUES>                           137,386,257
<CGS>                                       89,797,884
<TOTAL-COSTS>                               89,797,884
<OTHER-EXPENSES>                            34,441,660
<LOSS-PROVISION>                             2,024,847
<INTEREST-EXPENSE>                           4,414,701
<INCOME-PRETAX>                              8,940,122
<INCOME-TAX>                                 2,724,150
<INCOME-CONTINUING>                          6,215,972
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 6,215,972
<EPS-PRIMARY>                                     1.25
<EPS-DILUTED>                                     1.21
        

</TABLE>
<PAGE>   1

HANCOCK FABRICS, INC.                                                 EXHIBIT 11
COMPUTATION OF EARNINGS PER SHARE
(unaudited)

<TABLE>
<CAPTION>
(dollars in thousands, except for
  per share amounts)                                         Thirteen Weeks Ended

                                                         May 2,                 May 3,
                                                          1999                   1998
                                                      -----------            -----------

<S>                                                   <C>                    <C>
Basic earnings per share

  Net earnings                                        $     1,104            $     2,107
                                                      ===========            ===========

  Weighted average number of common shares
   outstanding during period                           18,149,429             20,684,389
                                                      ===========            ===========

Basic Earnings per share                              $      0.06            $      0.10
                                                      ===========            ===========



Diluted earnings per share

  Net earnings                                        $     1,104            $     2,107
                                                      ===========            ===========

  Weighted average number of common shares
   outstanding during period                           18,149,429             20,684,389


   Common stock equivalents                                     0                435,379

   Contingently issuable shares                                 0                 79,893
                                                      -----------            -----------

                                                       18,149,429             21,199,661
                                                      ===========            ===========

Diluted earnings per share                            $      0.06            $      0.10
                                                      ===========            ===========
</TABLE>
Exhibit 31

SEMT 2013-4

EX-31 Rule 13a-14(d)/15d-14(d) Certification.

I, Christopher J. Abate, certify that:

1.    I have reviewed this report on Form 10-K and all reports on Form 10-D required to be filed in respect of the period covered by this report on Form 10-K of Sequoia Mortgage Trust 2013-4 (the
Exchange Act periodic reports);

2.    Based on my knowledge, the Exchange Act periodic reports, taken as
a whole, do not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;

3.    Based on my knowledge, all of the distribution, servicing and other information
required to be provided under Form 10-D for the period covered by this report is included in the Exchange Act periodic reports;

4.    Based on my knowledge and the servicer compliance statements required in this report under Item 1123 of Regulation
AB, and except as disclosed in the Exchange Act periodic reports, the servicers have fulfilled their obligations under the servicing agreements in all material respects; and

5.    All of the reports on assessment of compliance with servicing criteria for asset-backed securities and their related
attestation reports on assessment of compliance with servicing criteria for asset-backed securities required to be included in this report in accordance with Item 1122 of Regulation AB and Exchange Act Rules
13a-18 and 15d-18 have been included as an exhibit to this report, except as otherwise disclosed in this report. Any material instances of noncompliance described in
such reports have been disclosed in this report on Form 10-K.

In giving the certifications above,
I have reasonably relied on information provided to me by the following unaffiliated parties: Corelogic Tax Services, LLC, Assurant, Inc., Cenlar, FSB as Servicer, First Republic Bank as Servicer, Wells Fargo Bank, N.A. as Custodian and Master
Servicer, and Citibank, N.A. as Securities Administrator and Paying Agent.

Date: March 31, 2017



|                                                             
|-------------------------------------------------------------
|/s/ Christopher J. Abate                                     
|Signature                                                    
|                                                             
|Chairman of the Board, President and Chief Financial Officer 
|(senior officer in charge of securitization of the depositor)